PL378216A1 - Przeciwbakteryjna kompozycja do miejscowego stosowania na błony śluzowe i skórę - Google Patents

Przeciwbakteryjna kompozycja do miejscowego stosowania na błony śluzowe i skórę

Info

Publication number
PL378216A1
PL378216A1 PL378216A PL37821603A PL378216A1 PL 378216 A1 PL378216 A1 PL 378216A1 PL 378216 A PL378216 A PL 378216A PL 37821603 A PL37821603 A PL 37821603A PL 378216 A1 PL378216 A1 PL 378216A1
Authority
PL
Poland
Prior art keywords
composition
antimicrobial composition
skin
mucosal membranes
local use
Prior art date
Application number
PL378216A
Other languages
English (en)
Inventor
Jens Richard Pedersen
Torben Richard Pedersen
Original Assignee
Pedersen Medical A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK200301858A external-priority patent/DK200301858A/da
Application filed by Pedersen Medical A/S filed Critical Pedersen Medical A/S
Publication of PL378216A1 publication Critical patent/PL378216A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL378216A 2003-01-16 2003-12-30 Przeciwbakteryjna kompozycja do miejscowego stosowania na błony śluzowe i skórę PL378216A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK200301858A DK200301858A (da) 2002-01-16 2003-01-16 Antimikrobielt præparat til lokal anvendelse på hud og slimhinder

Publications (1)

Publication Number Publication Date
PL378216A1 true PL378216A1 (pl) 2006-03-20

Family

ID=32695534

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378216A PL378216A1 (pl) 2003-01-16 2003-12-30 Przeciwbakteryjna kompozycja do miejscowego stosowania na błony śluzowe i skórę

Country Status (10)

Country Link
US (1) US20060233781A1 (pl)
EP (1) EP1587539B1 (pl)
AT (1) ATE476199T1 (pl)
AU (1) AU2003287936A1 (pl)
CA (1) CA2551760A1 (pl)
DE (1) DE60333679D1 (pl)
DK (1) DK1587539T3 (pl)
NO (1) NO335291B1 (pl)
PL (1) PL378216A1 (pl)
WO (1) WO2004060397A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340019B (es) 2010-11-23 2016-06-22 Pantheryx Inc Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas.
US9913903B2 (en) * 2015-08-06 2018-03-13 Grifols Worldwide Operations Limited Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
EP3479699A1 (en) * 2017-11-03 2019-05-08 Agriculture and Food Development Authority (TEAGASC) A composition and uses thereof
CN117717612A (zh) * 2023-12-19 2024-03-19 中山自然说生物科技有限公司 一种私密护理组合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
FR2573627B1 (fr) 1984-11-29 1986-12-26 Entremont Sa Procede pour la fabrication de produits laitiers au moyen d'anticorps
GB8906796D0 (en) 1989-03-23 1989-05-10 Medical Research Interntional Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions
RU2070889C1 (ru) * 1993-03-30 1996-12-27 Институт пищевых веществ РАН Лизоцимполисахаридный конъюгат
AU6880798A (en) 1998-04-02 1999-10-25 Procter & Gamble Company, The Multiple zone member
JP2000270858A (ja) * 1999-03-26 2000-10-03 Taiyo Kagaku Co Ltd リゾチーム糖複合体
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms

Also Published As

Publication number Publication date
EP1587539B1 (en) 2010-08-04
DK1587539T3 (da) 2010-11-08
EP1587539A1 (en) 2005-10-26
NO335291B1 (no) 2014-11-03
WO2004060397A1 (en) 2004-07-22
US20060233781A1 (en) 2006-10-19
CA2551760A1 (en) 2004-07-22
NO20053720L (no) 2005-08-02
ATE476199T1 (de) 2010-08-15
DE60333679D1 (de) 2010-09-16
AU2003287936A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
WO1999052515A3 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
WO2002007742A8 (en) Bacteriophage having multiple host range
WO2003077828A3 (en) Novel florfenicol-type antibiotics
EP2279662A3 (en) 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent
EP1075837A3 (en) Process for the preparation of aqueous formulations for ophthalmic use
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
CA2391659A1 (en) Crystal forms of azithromycin
WO2007028012A3 (en) Antibacterial 6'-n-modified 4,5-substituted aminoglycoside analogs
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
EP2316466A3 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
WO2004098536A3 (en) Anti-viral activity of cathelicidin peptides
NO20053720L (no) Antimikrobielt preparat for lokal anvendelse pa slimhinnemembraner og hud
EP1670490A4 (en) METHOD FOR INHIBITING BACTERIAL COLONIZATION
WO2006129092A3 (en) Use of bacteriophage in medicaments
CA2332686A1 (en) Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates
WO2002070638A3 (en) Essential oil from.coleus forskohlii, production process and use as antimicrobial agent
WO2003024996A3 (de) Antibakterielle makrozyklen
AU2002365083A8 (en) Composition and method to treat viral bacterial and parasitic infections and infestations
WO2022109317A9 (en) Anti-influenza antibodies and combinations thereof
AU2002314331A1 (en) Bacteriophage preparation for the treatment of intracellular bacterial infection
CA2404210A1 (en) Pharmaceutical gel composition
WO2003079980A3 (en) Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)